APA

Ho S., Chen P., Chen C., Tsai N., Lin Y., Lin C., Chuang C., Huang X., Chan Y., Liu Y., Chung C., Weng S. & Liao K. (20201105). Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. : Journal of nanobiotechnology.

Chicago

Ho Shu-Yi, Chen Pin-Rong, Chen Chia-Hung, Tsai Nu-Man, Lin Yu-Hsin, Lin Chen-Si, Chuang Cheng-Hsun, Huang Xiao-Fan, Chan Yi-Lin, Liu Yen-Ku, Chung Chen-Han, Weng Shun-Long and Liao Kuang-Wen. 20201105. Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. : Journal of nanobiotechnology.

Harvard

Ho S., Chen P., Chen C., Tsai N., Lin Y., Lin C., Chuang C., Huang X., Chan Y., Liu Y., Chung C., Weng S. and Liao K. (20201105). Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. : Journal of nanobiotechnology.

MLA

Ho Shu-Yi, Chen Pin-Rong, Chen Chia-Hung, Tsai Nu-Man, Lin Yu-Hsin, Lin Chen-Si, Chuang Cheng-Hsun, Huang Xiao-Fan, Chan Yi-Lin, Liu Yen-Ku, Chung Chen-Han, Weng Shun-Long and Liao Kuang-Wen. Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. : Journal of nanobiotechnology. 20201105.